HormoneStacks library
Find medically reviewed guides on TRT, peptides, hormone stacks, bloodwork, and men's hormone health.
Condition guide
First confirm the result with a sensitive male estradiol assay and assess symptoms, testosterone dose, injection pattern, body composition, medications, and other causes. Do not automatically add an aromatase inhibitor based on a single number; discuss the result with the prescribing clinician.
Protocol
What common hormone and metabolic labs measure and how timing affects interpretation.
Guide
Foundational guide to male hormones, symptoms, testing, and clinical interpretation.
Clinical question
Most treatment plans include baseline testing, repeat labs after a dose or formulation change, and periodic monitoring once stable. Timing varies by medication, symptoms, risk factors, and guideline; a common pattern is an early follow-up around 6–8 weeks and stable monitoring about every 6 months.
Compound profile
TRT ester overview, half-life, injection schedules, monitoring, and clinical questions.
Condition guide
Exogenous testosterone can suppress LH and FSH, reducing intratesticular testosterone and sperm production. Some men pursue fertility-preservation strategies, but there is no universal guarantee; semen analysis and reproductive-endocrinology guidance are important before and during treatment.
Guide
A practical overview of testosterone replacement therapy, evaluation, monitoring, and risks.
Comparison
Aromasin is the brand name for exemestane, an irreversible aromatase inhibitor, while Arimidex is the brand name for anastrozole, a reversible aromatase inhibitor. Neither should be used simply to normalize a lab number; treatment decisions should consider symptoms, a sensitive assay, and clinician evaluation.
Compound profile
Mechanism, research status, dosing context, safety, and sourcing considerations.
Compound profile
GHRH analog mechanisms, DAC versus no-DAC, research limits, and safety questions.
Comparison
CJC-1295 is a growth-hormone-releasing hormone analog, while ipamorelin is a growth-hormone secretagogue that acts at the ghrelin receptor. They are sometimes discussed together because their mechanisms may be complementary, but both require careful medical review and neither should be treated as a proven anti-aging therapy.
Comparison
HCG acts like luteinizing hormone at the testes, while enclomiphene is a selective estrogen receptor modulator that can increase pituitary LH and FSH signaling. The choice depends on the treatment goal, fertility status, laboratory findings, and clinician supervision.
Compound profile
Selective growth-hormone secretagogue overview, evidence, and clinical cautions.
Condition guide
Possible symptoms include reduced libido, erectile difficulty, low energy, depressed mood, reduced muscle mass, and infertility, but these symptoms have many causes. Diagnosis requires compatible symptoms plus consistently low morning testosterone on properly collected repeat testing, interpreted by a clinician.
Compound profile
GLP-1 therapy evidence, uses, monitoring, and questions to discuss with a clinician.
Comparison
Semaglutide is a GLP-1 receptor agonist, while tirzepatide activates both GIP and GLP-1 receptors. Clinical trials generally show greater average weight loss with tirzepatide, but the appropriate option depends on indication, tolerability, access, medical history, and clinician supervision.
Compound profile
Thymosin beta-4 analog research, tissue repair context, and safety considerations.
Compound profile
GIP/GLP-1 therapy evidence, weight-loss outcomes, and safety considerations.